Cree Research and Development Expense (Quarterly):
41.45M for March 31, 2017Cree Research and Development Expense (Quarterly) Chart
Cree Historical Research and Development Expense (Quarterly) Data
| Data for this Date Range | |
|---|---|
| March 31, 2017 | 41.45M |
| Dec. 31, 2016 | 28.07M |
| Sept. 30, 2016 | 28.53M |
| June 30, 2016 | 41.48M |
| March 31, 2016 | 41.87M |
| Dec. 31, 2015 | 31.56M |
| Sept. 30, 2015 | 32.73M |
| June 30, 2015 | 45.26M |
| March 31, 2015 | 43.82M |
| Dec. 31, 2014 | 46.99M |
| Sept. 30, 2014 | 46.72M |
| June 30, 2014 | 48.58M |
| March 31, 2014 | 46.63M |
| Dec. 31, 2013 | 44.44M |
| Sept. 30, 2013 | 41.74M |
| June 30, 2013 | 39.36M |
| March 31, 2013 | 39.04M |
| Dec. 31, 2012 | 39.94M |
| Sept. 30, 2012 | 37.55M |
| June 30, 2012 | 36.92M |
| March 31, 2012 | 36.15M |
| Dec. 31, 2011 | 35.89M |
| Sept. 30, 2011 | 34.40M |
| June 30, 2011 | 30.05M |
| March 31, 2011 | 31.02M |
| Dec. 31, 2010 | 29.23M |
| Sept. 30, 2010 | 24.73M |
| June 30, 2010 | 21.54M |
| March 31, 2010 | 20.37M |
| Dec. 31, 2009 | 19.32M |
| Sept. 30, 2009 | 20.17M |
| June 30, 2009 | 18.58M |
| March 31, 2009 | 17.07M |
| Dec. 31, 2008 | 18.44M |
| Sept. 30, 2008 | 17.28M |
| June 30, 2008 | 15.76M |
| March 31, 2008 | 15.40M |
| Dec. 31, 2007 | 14.90M |
| Sept. 30, 2007 | 12.78M |
| June 30, 2007 | 14.06M |
| March 31, 2007 | 15.80M |
| Dec. 31, 2006 | 14.61M |
| Sept. 30, 2006 | 14.37M |
| June 30, 2006 | 13.96M |
| March 31, 2006 | 13.33M |
| Dec. 31, 2005 | 14.78M |
| Sept. 30, 2005 | 12.79M |
| June 30, 2005 | 9.174M |
| March 31, 2005 | 10.89M |
| Dec. 31, 2004 | 10.29M |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
CREE Research and Development Expense (Quarterly) Benchmarks
| Companies | |
|---|---|
| Benchmark Electronics | |
| Jabil | 7.274M |
| Plexus |
CREE Research and Development Expense (Quarterly) Range, Past 5 Years
| Minimum | 28.07M | Dec 2016 |
| Maximum | 48.58M | Jun 2014 |
| Average | 40.30M |
CREE Research and Development Expense (Quarterly) Excel Add-In Codes
- Metric Code: r_and_d_expense
- Latest data point: =YCP("CREE", "r_and_d_expense")
- Last 5 data points: =YCS("CREE", "r_and_d_expense", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
CREE News
Business Wire 07/19 09:00 ET
